LakeShore Biopharma Co., Ltd. - Ordinary Shares, par value $0.0002 per share (LSBCF)
CUSIP: G9845F208
Q3 2025 13F Holders as of 30 Sep 2025
- Type / Class
- Equity / Ordinary Shares, par value $0.0002 per share
- Shares outstanding
- 41,218,298
- Total 13F shares
- 24,757
- Share change
- -298,710
- Total reported value
- $18,075
- Price per share
- $0.73
- Number of holders
- 1
- Value change
- -$304,684
- Number of sells
- 6
Quarterly Holders Quick Answers
What is CUSIP G9845F208?
CUSIP G9845F208 identifies LSBCF - LakeShore Biopharma Co., Ltd. - Ordinary Shares, par value $0.0002 per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP G9845F208:
Top shareholders of LSBCF - LakeShore Biopharma Co., Ltd. - Ordinary Shares, par value $0.0002 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Fung Ching Wong |
13D/G
|
— |
24%
|
9,836,010
|
$9,639,290 | $0 | 11 Jul 2025 | |
| FMR LLC |
13F
|
Company |
0.28%
|
116,508
|
$118,838 | — | 30 Jun 2025 | |
| HHLR ADVISORS, LTD. |
13F
|
Company |
0.18%
|
75,179
|
$76,683 | — | 30 Jun 2025 | |
| ORBIMED ADVISORS LLC |
13F
|
Company |
0.13%
|
54,799
|
$55,895 | — | 30 Jun 2025 | |
| SUPERSTRING CAPITAL MANAGEMENT LP |
13F
|
Company |
0.07%
|
30,792
|
$31,408 | — | 30 Jun 2025 | |
| BARCLAYS PLC |
13F
|
Company |
0.06%
|
24,757
|
$25,252 | — | 30 Jun 2025 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.04%
|
14,963
|
$15,262 | — | 30 Jun 2025 | |
| UBS Group AG |
13F
|
Company |
0.02%
|
6,469
|
$6,598 | — | 30 Jun 2025 |
Institutional Holders of LakeShore Biopharma Co., Ltd. - Ordinary Shares, par value $0.0002 per share (LSBCF) as of Q3 2025
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2025 vs Q2 2025 Across Filers
| Investor | Q2 2025 Shares | Q3 2025 Shares | Share Diff | Share Chg % | Q2 2025 Value $ | Q3 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
An asterisk sign (*) next to the price indicates that the price is likely invalid.